Benign multiple sclerosis: Some recent ideas

Current Neurology and Neuroscience Reports

Volumn 8, Issue 1, 2008, Pages 1-4

  Dawson, David M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BRAIN ATROPHY; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; GENETIC HETEROGENEITY; HEALTH SURVEY; HUMAN; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; RELIABILITY; SYMPTOMATOLOGY;

CENTRAL NERVOUS SYSTEM; DIAGNOSTIC ERRORS; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; INCIDENCE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PREDICTIVE VALUE OF TESTS; SAMPLE SIZE;

EID: 38649100387     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-008-0001-6     Document Type: Note

References (16)

1. McAlpine D: The benign form of multiple sclerosis: a study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. Brain 1961, 84:1186-1203.
2. Hutchinson M: Disability due to multiple sclerosis: a community-based study on an Irish county. Ir Med J 1986, 79:48-50.
3. Brex PA, Ciccarelli O, O'Riordan JL, et al.: A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002, 346:158-164.
4. Phadke JG: Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis. Brain 1990, 113:1597-1628.
5. Sayao AL, Devonshire V, Tremlett H: Longitudinal follow-up of "benign" multiple sclerosis at 20 years. Neurology 2007, 68:496-500.
6. Pittock SJ, Mayr WT, McClelland RL, et al.: Change in MS related disability in a population-based cohort: a 10 year followup. Neurology 2004, 62:51-60.
7. Compston A, Confavreux C, Lassmann H, et al.: McAlpine's Multiple Sclerosis, edn 4. New York: Churchill Livingstone, Elsevier; 2006.
8. Poser S, Bauer HJ, Poser W: Prognosis of multiple sclerosis: results from an epidemiological area in Germany. Acta Neurol Scand 1982, 65:347-354.
9. Beck RW, Smith CG, Gal RW, et al.: Neurologic impairment 10 years after optic neuritis. Arch Neurol 2004, 61:1386-1389.
10. Poser CM, Paty DW, Scheinberg L, et al.: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
11. Hawkins S, McDonnell GV: "Benign: multiple sclerosis? Clinical course, long term followup, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999, 67:148-152.
12. Polman CH, Reingold S, Edan G, et al.: Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria" Ann Neurol 2005, 58:840-846.
13. Lebrun C, Benson C, Debouverie M: Unexpected MS: 5 year followup of 30 patients with MR imaging and clinical conversion profile. [abstract P04.082]. Presented at the American Academy of Neurology annual meeting. Boston, MA; April 28 to May 5, 2007.
14. Nielsen JM, Korteweg T, Barkhof F, et al.: Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 2005, 5:781-783.
15. De Stefano N, Battaglini M, Stromillo ML, et al.: Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006, 129:2008-2016.
16. Gauthier S, Liptak Z, Polgar-Turksanyi, et al.: Benign MS characterized by a lower rate of brain atrophy as compared to early MS [abstract]. Neurology 2007, 68(Suppl 1):A330.